What gene fragment does erlotinib hydrochloride act on?

Erlotinib hydrochloride is an oral targeted therapy drug mainly used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Its mechanism of action is closely related to specific gene fragments. The following is a detailed analysis of the gene fragments targeted by erlotinib hydrochloride:

1. EGFRgene fragment

Erlotinib hydrochloride mainly targets the epidermal growth factor receptor (EGFR) gene fragment. EGFR is a transmembrane protein that belongs to the tyrosine kinase receptor family and plays an important role in physiological processes such as cell growth, proliferation and differentiation. However, in some cases, the EGFR gene can become mutated, causing abnormal activation of the receptor, thereby promoting the growth and spread of tumor cells. Erlotinib hydrochloride inhibits the proliferation and metastasis of tumor cells by inhibiting the tyrosine kinase activity of EGFR and blocking its signal transduction pathway.

2. EGFRGene mutation types

Erlotinib hydrochloride has significant efficacy against sensitive mutation types of EGFR gene. These sensitive mutations mainly include exon 19 deletion (Del19) and exon 21 (L858R) point mutation. Clinical studies have shown that after treatment with erlotinib hydrochloride, NSCLC patients with these sensitive mutations experienced significantly longer tumor shrinkage and disease stabilization time, and improved quality of life. Therefore, before using erlotinib hydrochloride, it is crucial to conduct EGFR gene mutation testing on patients to ensure the effectiveness and pertinence of the drug.

3. The relationship between drug action mechanism and gene fragments

The mechanism of action of erlotinib hydrochloride is closely related to the mutation status of EGFR gene fragment. The drug binds to EGFR and inhibits its autophosphorylation, thereby preventing the activation of downstream signaling pathways. These signaling pathways include Ras/Raf/MEK/ERK, PI3K/AKT, etc., which play an important role in the growth, differentiation, and apoptosis of tumor cells. By inhibiting the activity of these signaling pathways, erlotinib hydrochloride can effectively inhibit the proliferation and metastasis of tumor cells.